Search results
Results from the WOW.Com Content Network
Metformin is a trusted treatment for type 2 diabetes, but some people are being prescribed the drug for weight loss. ... Metformin has relatively mild side effects. At higher doses in particular ...
Metformin is a pleiotropic drug, with extensive off-target activity beyond its antidiabetic effect. Much of this has been attributed to its action on AMPK, although other mechanisms have been proposed. [221] [222] Metformin has been studied for its effects on multiple other conditions, including: Non-alcoholic fatty liver disease [223] [224] [225]
A recall has been ordered for a high-profile diabetes drug after producers discovered it contained alarmingly high levels of a cancer-causing impurity. Marksans Pharma Limited has recalled ...
Metformin — a biguanide — is an oral diabetes medication that helps keep blood sugar in check by causing the liver to produce less glucose. It was approved by the FDA in 1994 for the treatment ...
i think the relative importance of using metformin in the treatment of type 2 diabetes mellitus should be underlined given the results of the united kingdom prospective diabetes study (ukpds). it was the only agent that reduced cardiovascular mortality and morbidity - if i had type 2, i'd be the first in line to want metformin, ahead of sulphonylureas etc.
It is a treatment option after metformin and sulfonylureas. [8] It is given by injection under the skin. [7] Common side effects include low blood sugar, nausea, dizziness, abdominal pain, and pain at the site of injection. [7] Other serious side effects may include medullary thyroid cancer, angioedema, pancreatitis, and kidney injury. [7]
One theory is that metformin has anti-tumor side effects because it lowers insulin levels and keeps tumor cells from multiplying. Still, more research is needed. Inside Creative House/istockphoto
The most common side-effects are upper respiratory tract infection, diarrhea, combined edema/peripheral edema and headache, respectively. Most clinical adverse events were similar between groups treated with pioglitazone in combination with metformin and those treated with pioglitazone monotherapy. [medical citation needed]